Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Entain reports better-than-expected H1 performance

(Sharecast News) - Bookmaker Entain reported a better-than-expected H1 performance on Tuesday, with strong momentum across its UK, US, and Brazilian operations prompting an upgrade to FY guidance. Entain said total net gaming revenues rose 7% year-on-year to £2.63bn, while underlying earnings climbed 11% to £583m. UK and Ireland online operations led the charge with 21% growth, reflecting market share recovery and enhanced customer engagement. Its Brazilian arm also posted a 21% increase, principally due to its newly regulated framework.

The FTSE 100-listed group said its 50/50 joint venture with MGM Resorts, BetMGM, had delivered a standout performance in the half, with revenues up 35% as underlying earnings swung to a $109m profit. It now expects BetMGM to generate at least $2.7bn in FY revenues and EBITDA of $150m.

Entain said its strong H1 performance had supported an upgraded expectation of approximately 7% online net gaming revenue growth on a constant currency basis, or mid-single-digit growth on a reported basis, and also introduced FY25 group EBITDA guidance in the range of £1.1bn to £1.15bn.

However, despite the operational strength, Entain reported a post-tax loss of £116.9m, largely due to £50m in provisions related to AUSTRAC proceedings in Australia.

Entain, which declared an interim dividend of 9.8p per share, also revealed that Pierre Bouchut had been appointed as permanent non-executive chair, following his interim appointment back in February.

Chief executive Stella David said: "I am delighted by the ongoing momentum and strong performance that both Entain and BetMGM have delivered in H1 2025. Entain's transformation journey is well underway, gathering pace and is supported by our high-quality portfolio of iconic brands with podium positions in attractive markets. Our business is getting stronger, fitter and faster, with these results reinforcing our confidence in driving sustainable underlying growth and generating more than £0.5bn of cash annually in the medium term."

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.